With prof. Iwona Schymalla talks with Dorota Zozulińska-Ziółkiewicz, president of the Polish Diabetes Society.
New tools in the treatment of diabetes are a real revolution
Published April 19, 2022 11:29
Prof. Dorota Zozulińska-Ziółkiewicz:
- Continuous glucose monitoring systems are a breakthrough.
- On the one hand, it is the patient's comfort (no need to puncture), and on the other hand - continuous insight into glycaemia, which enables more effective prevention of the undesirable consequences of hyper- and hypoglycemia.
- These systems also bring a change in the quality of dialogue between the patient and the therapeutic team.
- Provides better efficacy and safety in diabetes therapy.
- In women with pre-pregnancy diabetes, continuous monitoring systems help to prepare for pregnancy.
- Pregnant with type 1 diabetes in Poland - both in the planning period and already pregnant, our patients use continuous glucose monitoring systems combined with insulin pumps (this is the action of the Great Orchestra of Christmas Charity) - here we have good treatment results and improved results obstetrics.
- We encounter type 2 diabetes more and more frequently. In these cases, the treatment pathway recommended by the standards is insulin therapy.
- Continuous glycemic monitoring seems to be an absolutely necessary tool for the safe achievement of appropriate glycemic targets during insulin therapy in pregnancy.
- There is an urgent need to expand the indications for the use of type 2 diabetes modifying drugs (GLP-1 analogues, phosin and metformin). The recommendations of the Polish Diabetes Association indicate groups of patients who should have access to these drugs.
- In some type 2 diabetic patients who require insulin therapy, the use of modern diabetes-modifying medications can reduce insulin doses or even discontinue insulin.
- With these drugs, we introduced the concept of "deinsulinization".
- Their effect on body weight is also very important.













